Cancer: When Cell Growth Goes Wrong

Treatment Regimen For Cancer
Credit: CancerCenter

Cancer is one of the leading causes of death around the globe. Furthermore, it is the subject of research by most scientists. To serve humanity many researchers are working to find the cause, cure, and ways to prevent it. To encourage scientists and researchers different awards are given to them. Similarly, the National Health Institute gives NIH Director’s New Innovator Award. The aim of giving this award is to encourage and help scientists in their innovative research.


Cancer is a disease in which abnormal cell growth increases. These abnormal cells do not function like normal cells. Furthermore, it can spread from one site to another within the body of the patient. Hence, a tumor can be a benign tumor or a malignant tumor. Abnormality in cell growth due to carcinogens can occur in any type of human body’s cells. However, the most common type in women is breast cancer, while in men lung cancer is the most common. 

ALSO READ: Can Cheese Lower Your Risk Of Cancer?

The treatment of cancer depends on the patient’s physical and financial condition. Furthermore, it depends upon the stage and progression of cancer. The most common treatment strategies include surgery, radiotherapy, chemotherapy, and medications.

However, there are other therapies available to shrink, cure, or stop the progression of tumor. These therapies include bone marrow therapy, immunotherapy, hormone therapy, targeted drug therapy, cryoablation, radiofrequency ablation, and clinical trials.

NIH Director’s New Innovators Award

The NIH New Innovators Award came into being in 2007. The NIH New Innovators Award is part of the common fund’s High Risk, High-Reward Research program. Moreover, this year an innovative cancer researcher received this award. Furthermore, these funds support biomedical, behavioral sciences, and social sciences discoveries. NIH has been giving three additional awards.

These are the NIH Director’s Pioneer Award, NIH Director’s Transformative Research Award, and NIH Director’s Early Independence Award. Furthermore, the Office of the Director in partnership with another component NIH Institutes and Centers manages these awards. 

NIH gives this award to those researchers who have completed their innovative research or postgraduate clinical training within ten years. Furthermore, to those who previously did not have support from NIH previously. Moreover, these researchers are known as early-stage investigators. Any early-stage investigators with their innovative ideas can apply for the awards.

There is no need for experimental data submission. However, they have to fill out a 10-page application. Addressing the problem, its possible solution, how the research is innovative, what makes the investigator well-suited for continuing the study. Katharine White receives the award for her research relating to cancer. 

ALSO READ: Coffee, Even the Decaf Version, Can Make Colon Cancer Patients’ Conditions Better

 Innovative Cancer Research And NIH Director’s New Innovators Award

Katharine Whites is an assistant professor of chemistry and biology at the University of Notre Dame. Her research is regarding cancer and is highly impactful on human health. The research focuses on improving cancer treatment. Furthermore, the primary focus of the study is the relationship between pH levels of cancer cells and pH levels of normal cells.

Through this research, it will become easy to know how changes in chemical composition alter pH levels. Also, determination of the impact of these alterations on cell biology within cancer cells and normal cells will become easy.  

Junior Michael Siroky has been working in White’s lab since June 2019. According to Michael, this research has the potential to reverse the effects of cancer growth. Additionally, the study enables us to know the impact of dysregulation of pH in cancer cells. And especially the influence on cancer cell growth, metastasis, and metabolic adaptions.

Furthermore, the research aims to use new chemicals to investigate cell biology, interlinking cell chemistry, and cell biology. Due to the innovative research, Katherine receives the Director’s New Innovators Award. The funds Katherine receives through this award will help her lab studies. Furthermore, it will enable her and her team to dive into sub-topics of her research. 

Adeena Tariq Lari
The author is a graduate of dental surgery from the Dow University Health Sciences, Karachi. She has an academic background in content writing as well as English literature, giving her an edge in the field. Adeena is always curious about physical and mental health. She is always passionate about research and delivering high-quality reliable content to users.